Table 2 Differences between patients with and without hyperacusis.
No hyperacusis | Hyperacusis | p Value | |
---|---|---|---|
No of patients | 25 | 15 | |
Sex (F/M)* | 25/0 | 13/2 | 0.061 |
Age (y)† (mean (SD)) | 42.7 (9.6) | 40.6 (11.3) | 0.538 |
Disease duration (y)† (mean (SD)) | 10.4 (4.9) | 13.1 (10.5) | 0.365 |
Type of onset | |||
Unknown | 8 | 3 | |
Contusion | 7 | 3 | |
Fracture | 4 | 6 | |
Operation or IV | 6 | 3 | |
Location of onset | |||
Upper extremity (L/R) | 3/5 | 3/4 | |
Lower extremities (L/R) | 4/13 | 0/8 | |
No of affected extremities | |||
1 | 2 | 0 | |
2 | 7 | 0 | |
3 | 6 | 6 | |
4 | 10 | 9 | |
Spreading pattern | |||
None | 2 | 0 | |
Ipsilateral | 12 | 10 | |
Heterolateral | 9 | 3 | |
Diagonal | 2 | 2 | |
VAS pain (0–100 mm)† (mean (SD)) | 68.7 (16.1) | 75.4 (16.4) | 0.278 |
Movement disorders | |||
Dystonia | 15 | 6 | |
Dystonia + tremor | 5 | 1 | |
Dystonia + myoclonia | 4 | 7 | |
Dystonia + tremor + myoclonia | 1 | 1 | |
Allodynia and/or hyperalgesia* | 0.026 | ||
Yes | 13 | 13 | |
No | 12 | 2 |
VAS, Visual Analogue Scale.
*the χ2 test; †the t test for independent samples.